In 2005, WHO added mifepristone and misoprostol to its complementary List of Essential Medicines for countries where abortion is not against the law. The List of Essential Medicines contains those medicines which are considered to satisfy the priority health needs of the population of developing countries, and which have been selected on the basis of their efficacy, safety and cost-effectiveness.